GLP Watchdog

Embody vs Noom

Neither Embody nor Noom has an FDA warning letter on record. On compounded semaglutide injection, Embody costs $1,200 less a year at standing rates: $79 a month against $179 a month at Noom.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / Noom

Featured pick (affiliate partner)

Embody logo

Embody

9.3/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
All 50 states and DC
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Embody
Visit Noom

Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Noom pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Noom 5.8). How we are paid

What the record shows

  1. 01

    Neither Embody nor Noom has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. Noom names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Embody costs $1,200 less a year at standing rates: $79 a month against $179 a month at Noom.

  4. 04

    Only Embody lists a price for compounded tirzepatide injection and compounded oral tirzepatide. Only Noom lists a price for brand-name tirzepatide pen.

  5. 05

    Embody lists all 50 states and DC. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

Noom

Compounded semaglutide injection

$79/moLower

$948 a year

$179/mo

$2,148 a year

Compounded tirzepatide injection

$129/mo

$1,548 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$349/mo

$4,188 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
Not stated
Refunds
No refunds once paid; a partial refund only after a medical disqualification
Refunds only before a prescription is written; renewal charges are not refunded
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Embody: October 30, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
Featured pick (affiliate partner)
  • $1,200 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection and compounded oral tirzepatide, which Noom does not price
  • Names its compounding pharmacy
Visit Embody

The case for Noom

5.8/10
  • Sells brand-name tirzepatide pen, which Embody does not price
  • Names no compounding pharmacy
  • Publishes no state list
Visit Noom

Scores

Embody 9.3 · Noom 5.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
0.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs Noom: questions

Neither Embody nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. Noom names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $1,200 a year at standing rates. Embody: $79 a month, about $948 a year. Noom: $179 a month, about $2,148 a year.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Noom pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Noom 5.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks